Erdafitinib
Products in Health Canada’s databases that list Erdafitinib as a medicinal or active ingredient, under this spelling. The same substance can be listed under another name (a salt, a common name), which has its own page.
- Drug products
- 4
- 4 authorized now
- Natural health products
- 0
- 0 active licences
- Notices of Compliance
- 9
- Products in all
- 4
Drug products
Authorized products first.
| Name | DIN | Status | Holder | Status since |
|---|---|---|---|---|
| BALVERSA (3 MG) | 02493217 | Marketed | Janssen Inc. | |
| BALVERSA (4 MG) | 02493225 | Marketed | Janssen Inc. | |
| BALVERSA (5 MG) | 02493233 | Marketed | Janssen Inc. | |
| BALVERSA (4 MG) | 02493241 | Approved | Janssen Inc. |
Notices of Compliance
Approvals of drug submissions that list it, newest first.
- BALVERSADecember 18, 2025 · NOC 36603
- BALVERSAFebruary 5, 2025 · NOC 34794
- BALVERSANovember 20, 2024 · NOC 34455
- BALVERSASeptember 25, 2024 · NOC 34232
- BALVERSAFebruary 7, 2024 · NOC 32658
- BALVERSAApril 6, 2023 · NOC 30481
- BALVERSANovember 22, 2021 · NOC 36084
- BALVERSAMarch 26, 2021 · NOC 25583
- BALVERSAOctober 25, 2019 · NOC 22821